美国医药监管机构在1983年到1992年期间批准了30种新抗生素,
Since 2003 they have approved just seven.
而从2003年至今,仅批准了七种。
Governments are keen to change this.
政府急于改变这一现状。
In February Tetraphase, a small company near Boston, won a $67m contract from America sBiomedical Advanced Research and Development Authority for an antibiotic that might treatboth anthrax outbreaks and serious infections in hospitals.
公司是一家位于波士顿附近的小公司,2月份时,它从美国生物医学高级研究发展局那里赢得了一份六千七百万美元的合同,研发一种抗生素,用于医院应对炭疽的突然爆发,治疗其他严重的细菌感染。
GSK also has a contract with BARDA to test an antibiotic for Gram-negative bacteria.However, the company recently suspended enrolments to its trial because of complicationsin some patients.
公司GSK和BARDA也签订了合同测试一种可抵抗革兰氏阴性细菌的抗生素,不过,由于一些病人出现并发症,最近该公司中止了试验的招募工作。
Seeking new ways to kill these vicious bugs is likely to be one of the main aims of theEuropean Commission s new partnership.
寻找新方法来消灭这些危险细菌很有可能是欧洲委员会寻求新的合作关系的主要目的之一。
【2015考研英语阅读制药商和抗生素】相关文章:
最新
2016-10-18
2016-10-11
2016-10-11
2016-10-08
2016-09-30
2016-09-30